Rakuyaku AI and Compound Safety Research Institute Fully Launch "CSR (BE) Editor" for Bioequivalence (BE) Trials on April 16
Rakuyaku AI, in collaboration with the Compound Safety Research Institute, has officially launched the "CSR (BE) Editor" for BE trials starting April 16.
📋 Article Processing Timeline
- 📰 Published: April 16, 2026 at 15:30
- 🔍 Collected: April 16, 2026 at 16:01 (31 min after Published)
- 🤖 AI Analyzed: April 19, 2026 at 02:46 (58h 44m after Collected)
A company that provides AI services contributing to the creation of specialized documents tailored to various industries such as pharmaceuticals, manufacturing, legal, patents, and finance, based on the customer base of over 6,000 companies and technological capabilities cultivated as Japan's largest leading AI translation company.